Friso Calkoen

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Anne M. Spanjaart, Per Ljungman, Rafael de la Cámara et al. · Leukemia · 2021 · 116 citations · Full text

Medicine, Hematology, Infectious Diseases +16

Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

Linde Dekker, Friso Calkoen, Yilin Jiang et al. · Blood Advances · 2022 · 85 citations · Full text

Medicine, Hematology, Pharmacology +16

BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response

María Alieva, Mario Barrera Román, Sam de Blank et al. · Nature Protocols · 2024 · 30 citations

Life Sciences, Bioengineering, Immunology +17

Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia

Valeria Ceolin, Erica Brivio, Harm van Tinteren et al. · Leukemia · 2022 · 28 citations · Full text

Medicine, Hematology, Oncology +16

Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses

Friso Calkoen, D. M. C. Brinkman, Carly Vervat et al. · Cytotherapy · 2013 · 22 citations

Medicine, Immunology, Pediatrics +13